<DOC>
	<DOCNO>NCT01010256</DOCNO>
	<brief_summary>The purpose study evaluate level specific protein ( PTEN ) cancer cell chronic myelomonocytic leukemia ( CMML ) patient . This protein might involve transformation normal blood cell leukemia cell . The PTEN protein investigate CMML specifically discover closely related cancer . If study demonstrate abnormality protein , future test design evaluate genetic abnormality result lack normal presence protein . The goal result study help develop new drug strategy treat future patient CMML understand abnormality disease cellular molecular level . The result study also utilized future study develop individualized treatment patient abnormal level protein .</brief_summary>
	<brief_title>The Expression PTEN Protein mRNA Malignant Cells Chronic Myelomonocytic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Acute</mesh_term>
	<mesh_term>Leukemia , Myelomonocytic , Chronic</mesh_term>
	<criteria>Subject must least 18 year old . Subject must sign informed consent . For study population , subject must CMML diagnosis base WHO 2009 criterion . For control population , subject must deem healthy hematologic disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>To evaluate phosphate tension homolog delete chromosome ten ( PTEN ) protein level leukemia cell patient CMML .</keyword>
	<keyword>To identify PTEN genetic defect patient deficient PTEN protein level .</keyword>
	<keyword>To evaluate role PTEN deregulation CMML pathogenesis .</keyword>
</DOC>